In line with our results, gp130 inhibition with the SERM bazedoxifene has been reported to result in a reduction of interleukin-11 induced STAT3 phosphorylation, proliferation and viability, as well as organoid and xenograft growth in colon cancer [46, 47]. Here, IL11 is linked to malignant colon neoplasm.